December 18, 2025
Alzheimer’s dementia is one of the greatest medical challenged our country faces (e.g., places an incredible burden upon society (e.g., last year it was estimated to cost the United States 360 billion dollars). Yet, despite spending billions for research each year, cures remain elusive, something many believe results from the flawed belief eliminating the amyloid plaques associated with Alzheimer’s will fix it.
In turn, as I showed here:
- Decades of amyloid therapies have never produced a beneficial therapy.
- The newest “breakthrough” amyloid eliminating monoclonal antibodies, at best, slightly slow the progression of Alzheimer’s while simultaneously causing a host of side effective including brain bleeding and swelling in over a quarter of recipients.
- The entire amyloid industry rests upon a fraudulent study no one wanted to retract, likely due to how much was invested in the amyloid hypothesis.
In short, the money behind this juggernaut has caused research into the real causes of Alzheimer’s to be suppressed. For example, here I highlighted how coconut oil MCT’s (safely) do more than any of the costly amyloid drugs—yet virtually no one knows this.
Dale Bredesen’s Discovery
Many are also unaware a 2022 study that should have revolutionized the entire Alzheimer’s field:
READ FULL ARTICLE HERE…
Home | Caravan to Midnight (zutalk.com)







Be First to Comment